InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: haoliepastor post# 239429

Wednesday, 09/05/2018 1:52:23 AM

Wednesday, September 05, 2018 1:52:23 AM

Post# of 403017
While Phase 1 and 2 trials for K included efficacy outcomes, K was never intended as a stand alone drug. The idea behind a p53 modulator is as a combination to enhance or add to efficacy of cancer drugs.

* Never borrow to invest.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News